Sable Bio
AI platform that helps pharma teams spot drug target safety risks earlier in discovery.
sablebio.com ↗Why it's here
Raised a $3.75M seed led by MMC Ventures in February 2026 and has commercial deals with three top-ten global pharma firms.
source: sablebio.com- Focus
- Drug Safety AI
- Founded
- 2023
- Latest round
- Seed, $3.75M, Feb 2026
- Staff (Companies House accounts)
- 6, average over the period to 31 Aug 2025source: find-and-update.company-information.service.gov.uk
- London office
- Runway East Aldgate, 2 Whitechapel Road, Tower Hamlets E1 1EWsource: sablebio.com
- London presence
- HQsource: sablebio.com
- Investors
- Nearest station
- Aldgate East, 378 m
- Visas
- Licensed visa sponsor, listed as SableBio Limitedsource: gov.uk
Verified 6 Oct 2026. How we verify · Suggest a fix